Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis;Correlação da intensidade do sinal em FLAIR e os níveis de mediadores inflamatórios no hipocampo de pacientes com epilepsia do lobo temporal e esclerose mesial temporal

Arquivos de Neuro-Psiquiatria

Volumn 69, Issue 1, 2011, Pages 91-99

  Varella, Pedro Paulo Vasconcellos ^a   Santiago, Joselita Ferreira Carvalho ^a   Carrete Jr , Henrique ^a   Higa, Elisa Mieko Suemitsu ^a   Yacubian, Elza Márcia Targas ^a   Centeno, Ricardo Silva ^a   Caboclo, Luís Otávio Sales Ferreira ^a   de Castro Neto, Eduardo Ferreira ^a   Canzian, Mauro ^b   Amado, Débora ^a   Cavalheiro, Esper Abrão ^a   da Graça Naffah Mazzacoratti, Maria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; FLAIR hippocampal signal; Glutamate and hippocampal sclerosis; NO

Indexed keywords

CD45 ANTIGEN; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 1BETA; NEUROTRANSMITTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; NEUROTRANSMITTER RELEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL PROCESSING; TEMPORAL LOBE EPILEPSY;

EID: 79952349864     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2011000100018     Document Type: Article

References (32)

1. Choi D, Na DG, Byun HS, et al. White-matter change in mesial temporal sclerosis: correlation of MRI with PET, pathology, and clinical features. Epilepsia 1999;40:1634-1641.
2. Mitchell LA, Jackson GD, Kalnins RM, et al. Anterior temporal abnormality in temporal lobe epilepsy: a quantitative MRI and histopathologic study. Neurology 1999;52:327-336.
3. Babb T. Pathological findings in epilepsy. 1 ed. New York: Raven Press; 1987.
4. Mathern GW, Adelson PD, Cahan LD, Leite JP. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res 2002;135: 237-251.
5. Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 1993;43: 719-725.
6. Cook MJ. MRI and epilepsy surgery. J Clin Neurosci 1996;3:325-326.
7. de Lanerolle NC, Lee TS. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav 2005;7:190-203.
8. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 2003;126:462-469.
9. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005;46:1724-1743.
10. Viviani B, Bartesaghi S, Gardoni F, et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23:8692-8700.
11. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002;67:161-172.
12. Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009;30:379-387.
13. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003;27:325-355.
14. Clarkson AN, Liu H, Pearson L, et al. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB J 2004;18:1114-1116.
15. Gilad GM, Gilad VH, Casanova MF, Casero Jr RA. Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol Psychiatry 1995;38:227-234.
16. Bloch-Boguslawska E. [The effect of the time of death on the reactivity of rat caudal artery regulated by NA with a simultaneous use of NOS, CG and COX inhibitors. Part I]. Arch Med Sadowej Kryminol 2006;56:136-143.
17. Blumcke I, Pauli E, Clusmann H, et al. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol 2007;113:235-244.
18. Cavalheiro EA, Fernandes MJ, Turski L, Naffah-Mazzacoratti MG. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 1994;35:1-11.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Hampl V, Walters CL, Archer SL. Determination of nitric oxide by the chemiluminescence reaction with ozone. In: Feelisch M, Stamler JS, (Eds). Methods in nitric oxide research. Chichester: John Wiley & Sons; 1996:310-318.
21. Cavus I, Pan JW, Hetherington HP, et al. Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients. Epilepsia 2008;49:1358-1366.
22. Eid T, Thomas MJ, Spencer DD, et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 2004;363:28-37.
23. Hoogland G, Hens JJ, De Wit M, et al. Glutamate and gamma-aminobutyric acid content and release of synaptosomes from temporal lobe epilepsy patients. J Neurosci Res 2000;60:686-695.
24. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744.
25. Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol 2001;63:125-149.
26. Allan SM, Rothwell NJ. Cortical death caused by striatal administration of AMPA and interleukin-1 is mediated by activation of cortical NMDA receptors. J Cereb Blood Flow Metab 2000;20:1409-1413.
27. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007;8:766-775.
28. Guix FX, Uribesalgo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 2005;76:126-152.
29. Lonart G, Wang J, Johnson KM. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 1992;220:271-272.
30. Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26:497-511.
31. Bauer S, Cepok S, Todorova-Rudolph A, et al. Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res 2009;86:82-88.
32. Carmeli E, Beiker R, Morad M. Nitric oxide and interlukin-6 levels in intellectual disability adults with epilepsy. Res Dev Disabil 2009;30:567-571.